Altria's $12.8B Juul bet lost a third of its value within a year

In December 2018 Altria, the tobacco giant, paid $12.8 billion for Juul, the e-cigarette maker that had already raised large sums from other investors. Crunchbase News reported at the time that Juul's then-attractive economics made it look like a safe bet — a lucrative hedge for a legacy tobacco company against the future of nicotine.

Things went sideways within a year. On October 31, 2019, Altria announced it had written down the investment by more than a third, recording a $4.5 billion pre-tax charge against its third-quarter earnings. The e-cigarette maker was now described as troubled, its prospects clouded by public outcry over vaping's effects on health.

Crunchbase News filed the charge under 'unicorn writedown season': the same week, Fidelity's Contrafund cut the value of its WeWork stake by 35% (about $100 million) after WeWork's failed IPO. The outlet's lesson: healthy-looking economics do not guarantee success, and investors had been 'far too optimistic' with startup valuations.

$4.5 billion pre-tax charge against Q3 2019 earnings — more than a third of the $12.8 billion Altria paid in December 2018.

Juul's appeal was priced on growth economics, but the stake's value depended on a public-health and regulatory perimeter Altria did not control.

Altria bought at the top of the private-market hype cycle: $12.8 billion reflected optimism about vaping's future, not a de-risked franchise.

The writedown landed in a single quarter — the carried value had been narrative, and the narrative flipped fast.

A strategic stake priced at the peak of a hype cycle can shed a third of its value in one quarter when the public narrative turns.

The article records only the first writedown — the $4.5 billion pre-tax Q3 2019 charge — and speculates that high-profile stumbles like Juul's and WeWork's could depress startup valuations in 2020 as investors relearn what companies are actually worth.